Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Miami
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Individuals diagnosed with ptosis undergoing conjunctival Muller's muscle resection evaluation.
Individuals who can tolerate and have no hypersensitivity to phenylephrine 2.5% ophthalmic solution.
Individuals who can tolerate eye-drop medications.
Individuals who are physically able to take a tangent screen visual field test.
Age: Adults who can comprehend the instructions and procedures (18+ years old)
You may not be if
\- This study will not incorporate any of the following at-risk populations: adults unable to consent, individuals who are not yet adults, pregnant women, prisoners.
This study will not include participants who refuse to consent.
This study will not include participants who are too tired or unable to take a tangent screen visual field test (see Risk to Subjects).
This study will not include individuals who may not be able to tolerate phenylephrine 2.5% ophthalmic solution.
Specifically, those with a past medical history of bradycardia, hypotension, autonomic dysfunction, or severe cardiovascular disease
This study will not include individuals who consume drugs contraindicated in phenylephrine use: Ergot Derivatives (Vasoconstrictive CYP3A4 Substrates), Iobenguane Radiopharmaceutical Products, Kratom, Lisuride, Monoamine Oxidase Inhibitors
Clareo Health | Phenylephrine Versus Eyelid Taping for Muller's Muscle-Conjunctival Resection (MMCR) Evaluation
